Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	GSK1838262 600 mg
Total, all-cause mortality	GSK1838262 450 mg
Total, all-cause mortality	GSK1838262 300 mg
Total, all-cause mortality	GSK1838262 Placebo Match
Total, other adverse events	GSK1838262 600 mg	55	122
Total, other adverse events	GSK1838262 450 mg	56	123
Total, other adverse events	GSK1838262 300 mg	33	121
Total, other adverse events	GSK1838262 Placebo Match	46	121
Total, serious adverse events	GSK1838262 600 mg	1	122
Total, serious adverse events	GSK1838262 450 mg	0	123
Total, serious adverse events	GSK1838262 300 mg	2	121
Total, serious adverse events	GSK1838262 Placebo Match	1	121

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01668667/event-totals